Showing results (151-160 of 177) with videos related to

Sort By:
Pageof 18
Bone Marrow Transplantation|April 11, 2020
CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II studyPooja Khandelwal, Tsuyoshi Fukuda, Ashley Teusink-Cross, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2016
A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell TransplantationPooja Khandelwal, Chie Emoto, Tsuyoshi Fukuda, et al.
Bone Marrow Transplantation|September 22, 2021
A prospective pilot study of a novel alemtuzumab target concentration intervention strategyDanielle E Arnold, Chie Emoto, Tsuyoshi Fukuda, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2015
Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab RegimenRebecca A Marsh, Marepalli B Rao, Aharon Gefen, et al.
Nature Medicine|May 26, 2025
Lentiviral gene therapy with reduced-intensity conditioning for sickle cell disease: a phase 1/2 trialMichael Grimley, Stella M Davies, Archana Shrestha, et al.
Blood Advances|April 6, 2018
Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritisJuliana M F Silva, Fani Ladomenou, Ben Carpenter, et al.
Cell|May 20, 2025
Arrestin-biased allosteric modulator of neurotensin receptor 1 alleviates acute and chronic painRan Guo, Ouyang Chen, Yang Zhou, et al.
The Lancet. Rheumatology|December 24, 2024
Allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease: outcomes from an international, retrospective cohort studyMichael G Matt, Daniel Drozdov, Elisabeth Bendstrup, et al.
Blood Advances|October 20, 2021
High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of AsiaBlachy J Dávila Saldaña, Tami John, Challice Bonifant, et al.
The Journal of Allergy and Clinical Immunology|August 20, 2022
Aberrant T-cell exhaustion in severe combined immunodeficiency survivors with poor T-cell reconstitution after transplantationRoxane Labrosse, Ines Boufaied, Benoîte Bourdin, et al.
Pageof 18